M&A Deal Summary |
|
|---|---|
| Date | 2019-02-21 |
| Target | MolecularMD |
| Sector | Life Science |
| Buyer(s) | ICON |
| Sellers(s) | Ballast Point Ventures |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 41,100 |
| Revenue | 8.1B USD (2023) |
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. ICON was founded in 1990 and is based in Dublin, Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 25 of 29 |
| Sector (Life Science) | 15 of 16 |
| Type (Add-on Acquisition) | 21 of 25 |
| State (Oregon) | 1 of 1 |
| Country (United States) | 16 of 18 |
| Year (2019) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-27 |
Mapi Group
Lyon, France Mapi Group is a provider of health research and commercialization services to life-science companies enabling market authorization, market access and market adoption of novel therapeutics. Mapi is based in Lyon, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-23 |
MeDiNova Research
Coventry, United Kingdom MeDiNova Research is a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland, and Romania. The company has experience operating a number of different site models, including dedicated research sites, integrated research sites and working closely with affiliate sites. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 550M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Ballast Point Ventures is a private investment firm that targets growth businesses located in the South US. Ballast Point looks to commit $1 to $5 million of equity capital per transaction and looks for businesses in markets with annual revenues of at least $100 million. Sectors of interest include healthcare, information technology (IT), financial services, communications, business services, and consumer products/services. Ballast Point Ventures was formed in 2001 and is based in St. Petersburg, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 32 |
| Sector (Life Science) | 3 of 3 |
| Type (Add-on Acquisition) | 12 of 12 |
| State (Oregon) | 1 of 1 |
| Country (United States) | 30 of 32 |
| Year (2019) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-05 |
YPrime
Malvern, Pennsylvania, United States YPrime provides software solutions and consulting services that enable efficient and collaborative clinical trial data collection and information management for biopharmaceutical companies and contract research organizations. YPrime's eClinical suite includes electronic clinical outcome assessments (eCOA), interactive response technology (IRT), and eClinical consulting and integration services. YPrime’s eCOA and IRT solutions are fully supported by experienced project management teams and combine configurability with customizable functionality to meet global clinical trial requirements. YPrime was founded in 2006 and is based in Malvern, Pennsylvania. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-09 |
Keen Decision Systems
Research Triangle, North Carolina, United States Keen Decision Systems is a software-as-a-service company whose unified marketing measurement and optimization platform help marketers make dynamic, data-driven decisions about the most effective marketing investments, by channel, investment level, and timing. Keen Decision Systems is based in Research Triangle, North Carolina. |
Buy | - |
